序号 |
标题 |
次数 |
作者 |
发布时间 |
86806 |
1189194-65-7,DOTA-CH2-Alkynyl (TFA salt) |
108 |
kx |
2024-11-21 |
86807 |
PAMAM-DOTA-Gd |
129 |
kx |
2024-11-21 |
86808 |
[βAla3]-α-MSH3-10 齐岳定制 |
119 |
zcy |
2024-11-21 |
86809 |
DOTA-lysine DOTA-赖氨酸 |
106 |
zcy |
2024-11-21 |
86810 |
177943-88-3,DOTA-TATE |
100 |
kx |
2024-11-21 |
86811 |
DOTA-pNO2-Phe-c (dCys-Tyr-dTrp-Lys-Thr-Cys) dTyrNH2 科研供应 |
106 |
zcy |
2024-11-21 |
86812 |
DOTA-d-Phe-NH2 科研定制 |
102 |
zcy |
2024-11-21 |
86813 |
甲基二苯乙炔基硅烷(MDPES) |
109 |
WYQ |
2024-11-21 |
86814 |
2,6二三聚茚基乙炔基BODIPY类近红外荧光染料 |
119 |
WYQ |
2024-11-21 |
86815 |
聚(间二乙炔基苯-甲基氢硅烷)(PSA) |
174 |
WYQ |
2024-11-21 |
86816 |
DOTA-type 齐岳定制 |
118 |
zcy |
2024-11-21 |
86817 |
乙炔基苯并噁嗪树脂(A-PBZ) |
135 |
WYQ |
2024-11-21 |
86818 |
DOTA-Arg-Gly-Asp-Ser-Pro-Lys-COOH |
151 |
kx |
2024-11-21 |
86819 |
DOTA-Maleimide,马来酰亚胺-DOTA |
169 |
kx |
2024-11-21 |
86820 |
DOTA-conjugated monomeric DOTA共轭的多价环状RGD肽树枝状大分子 |
104 |
zcy |
2024-11-21 |
86821 |
DOTA-Maleimide,马来酰亚胺-DOTA大环螯合剂 |
110 |
kx |
2024-11-21 |
86822 |
DOTA-E[c(RGDyK)2],金属离子螯合剂 |
147 |
kx |
2024-11-21 |
86823 |
乙炔基雌二醇(EE2)EE2是雌二醇的一种衍生物 |
664 |
WYQ |
2024-11-21 |
86824 |
DOTA-cyclo(RGDfK) |
92 |
kx |
2024-11-21 |
86825 |
聚(对亚苯基亚乙炔基-alt-间亚苯基亚乙炔基)(meta-PPEs) |
131 |
WYQ |
2024-11-21 |
86826 |
DOTA–ReCCMSH;DOTA偶联ReO环化黑色素瘤 |
117 |
zcy |
2024-11-21 |
86827 |
DOTA-cyclo(RGDfK) ,螯合物前体多肽 |
90 |
kx |
2024-11-21 |
86828 |
DOTA0-d-Phe1-Tyr3-octreotide,DOTA0-SMT487 齐岳定制 |
91 |
zcy |
2024-11-21 |
86829 |
RGD肽,DOTA-c(RGDfK),DOTA-cyclo(RGDfK) |
152 |
kx |
2024-11-21 |
86830 |
炔基化合物炔基胆碱(PCho) |
136 |
WYQ |
2024-11-21 |
86831 |
DOTA-(酪氨酸3)-奥曲肽,204318-14-9,DOTA-TOC |
94 |
kx |
2024-11-21 |
86832 |
炔基功能化的保护多巴胺(Alkynyl-SiDOPA) |
115 |
WYQ |
2024-11-21 |
86833 |
炔基封端的聚乙二醇单甲醚(Pro-PEG) |
163 |
WYQ |
2024-11-21 |
86834 |
3-乙炔基苯胺(APA) |
228 |
WYQ |
2024-11-21 |
86835 |
DOTA-4D5 DOTA偶联小鼠单克隆抗体4D5 |
107 |
zcy |
2024-11-21 |
86836 |
3,5-二氨基4′-苯炔基二苯甲酮(DPEB) |
116 |
WYQ |
2024-11-21 |
86837 |
端叠氮基聚乙二醇(ATPEG) |
126 |
WYQ |
2024-11-21 |
86838 |
DOTA-PEG-conjugated anti-TAG-72 单分散DOTA-PEG缀合的抗TAG-72双抗体 |
180 |
zcy |
2024-11-21 |
86839 |
204318-14-9,DOTA-(酪氨酸3)-奥曲肽 |
90 |
kx |
2024-11-21 |
86840 |
DOTA-Ph-Al-ioregf/r3 DOTA对溴乙酰氨基苄基偶联ioregfr3 |
107 |
zcy |
2024-11-21 |
86841 |
1006711-90-5,DOTA-Mal |
82 |
kx |
2024-11-21 |
86842 |
DOTA-PAMAM DOTA-PAMAM树状大分子 |
112 |
zcy |
2024-11-21 |
86843 |
CAS:619300-53-7,金属离子螯合剂DOTA-NOC |
113 |
kx |
2024-11-21 |
86844 |
porphyrin-amido-benzyl-DOTA 卟啉-p-NH2-苄基-DOTA缀合物 |
113 |
zcy |
2024-11-21 |
86845 |
170908-81-3,DOTA-NHS ester,DOTA活性酯 |
83 |
kx |
2024-11-21 |
86846 |
DOTA-SP DOTA-substance P DOTA偶联神经肽类似物 |
103 |
zcy |
2024-11-21 |
86847 |
DOTA-3-酪氨酰基-奥曲肽 |
84 |
kx |
2024-11-21 |
86848 |
CAS号2389064-47-3 DOTA-tris(TBE)-amido-dPEG4-TFP ester |
153 |
zyl |
2024-11-21 |
86849 |
C13-R8的简单介绍 |
101 |
kx |
2024-11-21 |
86850 |
DOTA-GGGF-ITC 齐岳定制 |
108 |
zcy |
2024-11-21 |